Rank | Gene Set | Z-score |
---|---|---|
1 | leukocyte aggregation (GO:0070486) | 6.56560359 |
2 | response to peptidoglycan (GO:0032494) | 6.02533859 |
3 | neutrophil activation involved in immune response (GO:0002283) | 5.99510789 |
4 | cellular extravasation (GO:0045123) | 5.45747990 |
5 | respiratory burst (GO:0045730) | 5.34403430 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.25876491 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.25876491 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.25876491 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.25876491 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.25876491 |
11 | modulation by symbiont of host immune response (GO:0052553) | 5.25876491 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.19110369 |
13 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.18266251 |
14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.91111992 |
15 | immunoglobulin mediated immune response (GO:0016064) | 4.64416232 |
16 | neutrophil activation (GO:0042119) | 4.61119971 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.59522108 |
18 | granulocyte activation (GO:0036230) | 4.53972672 |
19 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.27562375 |
20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.27105311 |
21 | negative regulation of interleukin-12 production (GO:0032695) | 4.21611740 |
22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.11144492 |
23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.08932316 |
24 | response to host immune response (GO:0052572) | 4.08932316 |
25 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.08549332 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.05625365 |
27 | neutrophil mediated immunity (GO:0002446) | 4.00901552 |
28 | detection of biotic stimulus (GO:0009595) | 3.93889201 |
29 | cellular response to zinc ion (GO:0071294) | 3.93339566 |
30 | macrophage activation involved in immune response (GO:0002281) | 3.90361578 |
31 | regulation of integrin activation (GO:0033623) | 3.89324628 |
32 | regulation of podosome assembly (GO:0071801) | 3.88788048 |
33 | superoxide anion generation (GO:0042554) | 3.85792460 |
34 | response to host (GO:0075136) | 3.74873524 |
35 | response to host defenses (GO:0052200) | 3.74873524 |
36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.74873524 |
37 | neutrophil chemotaxis (GO:0030593) | 3.74824998 |
38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71478106 |
39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.67070281 |
40 | leukocyte cell-cell adhesion (GO:0007159) | 3.66258217 |
41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64970576 |
42 | neutrophil migration (GO:1990266) | 3.64069972 |
43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.63264621 |
44 | detection of other organism (GO:0098543) | 3.62393326 |
45 | positive regulation of interferon-alpha production (GO:0032727) | 3.58317657 |
46 | reactive oxygen species biosynthetic process (GO:1903409) | 3.57658426 |
47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56597227 |
48 | negative regulation of cell killing (GO:0031342) | 3.56597227 |
49 | B cell mediated immunity (GO:0019724) | 3.56513389 |
50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.54640182 |
51 | positive regulation of protein homooligomerization (GO:0032464) | 3.52951933 |
52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.52194064 |
53 | response to fungus (GO:0009620) | 3.49812374 |
54 | defense response to fungus (GO:0050832) | 3.48420862 |
55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.47734947 |
56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.46349346 |
57 | response to interleukin-15 (GO:0070672) | 3.44860500 |
58 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.43117324 |
59 | regulation of interferon-alpha production (GO:0032647) | 3.38766428 |
60 | detection of bacterium (GO:0016045) | 3.38746194 |
61 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34481432 |
62 | * regulation of mast cell activation (GO:0033003) | 3.33534617 |
63 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.33333405 |
64 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.33333405 |
65 | * regulation of mast cell degranulation (GO:0043304) | 3.31461081 |
66 | response to muramyl dipeptide (GO:0032495) | 3.31423190 |
67 | regulation of tolerance induction (GO:0002643) | 3.30491101 |
68 | type I interferon signaling pathway (GO:0060337) | 3.29696008 |
69 | cellular response to type I interferon (GO:0071357) | 3.29696008 |
70 | regulation of B cell differentiation (GO:0045577) | 3.29101637 |
71 | myeloid cell activation involved in immune response (GO:0002275) | 3.27850359 |
72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.27760513 |
73 | regulation of T cell tolerance induction (GO:0002664) | 3.27469406 |
74 | response to type I interferon (GO:0034340) | 3.26553150 |
75 | * positive regulation of mast cell activation (GO:0033005) | 3.26473361 |
76 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24968062 |
77 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24250673 |
78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.23141834 |
79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20212102 |
80 | positive regulation of B cell differentiation (GO:0045579) | 3.19969958 |
81 | granulocyte chemotaxis (GO:0071621) | 3.19438604 |
82 | germinal center formation (GO:0002467) | 3.19260542 |
83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.16622852 |
84 | positive regulation of interferon-beta production (GO:0032728) | 3.14429838 |
85 | granulocyte migration (GO:0097530) | 3.13307418 |
86 | leukocyte mediated cytotoxicity (GO:0001909) | 3.12843749 |
87 | positive regulation of antigen processing and presentation (GO:0002579) | 3.11038769 |
88 | cellular response to interleukin-15 (GO:0071350) | 3.10478743 |
89 | * regulation of leukocyte degranulation (GO:0043300) | 3.07893836 |
90 | positive regulation of lamellipodium assembly (GO:0010592) | 3.07739228 |
91 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06568310 |
92 | leukotriene metabolic process (GO:0006691) | 3.06113620 |
93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05731909 |
94 | * regulation of mast cell activation involved in immune response (GO:0033006) | 3.05623092 |
95 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03192376 |
96 | positive thymic T cell selection (GO:0045059) | 3.01722024 |
97 | response to protozoan (GO:0001562) | 3.01539628 |
98 | myeloid leukocyte mediated immunity (GO:0002444) | 3.00316136 |
99 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.99405291 |
100 | negative regulation of innate immune response (GO:0045824) | 2.98754433 |
101 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.98453350 |
102 | negative regulation of phagocytosis (GO:0050765) | 2.98330047 |
103 | myeloid leukocyte activation (GO:0002274) | 2.96967615 |
104 | sequestering of metal ion (GO:0051238) | 2.96712185 |
105 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.96168940 |
106 | activated T cell proliferation (GO:0050798) | 2.95370811 |
107 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94785378 |
108 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94785378 |
109 | lipoxygenase pathway (GO:0019372) | 2.94244818 |
110 | chronic inflammatory response (GO:0002544) | 2.93705882 |
111 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.92796292 |
112 | negative thymic T cell selection (GO:0045060) | 2.92146741 |
113 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91343653 |
114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88266136 |
115 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.87329372 |
116 | detection of external biotic stimulus (GO:0098581) | 2.86905461 |
117 | regulation of antigen processing and presentation (GO:0002577) | 2.86364628 |
118 | defense response to protozoan (GO:0042832) | 2.85653592 |
119 | negative regulation of mast cell activation (GO:0033004) | 2.84536161 |
120 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83320053 |
121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.82087083 |
122 | negative regulation of interleukin-6 production (GO:0032715) | 2.80829643 |
123 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.79845843 |
124 | embryonic process involved in female pregnancy (GO:0060136) | 2.78808868 |
125 | T cell migration (GO:0072678) | 2.78546346 |
126 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77024259 |
127 | B cell receptor signaling pathway (GO:0050853) | 2.76108296 |
128 | leukocyte degranulation (GO:0043299) | 2.75872404 |
129 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.75419955 |
130 | detection of molecule of bacterial origin (GO:0032490) | 2.74540411 |
131 | microglial cell activation (GO:0001774) | 2.73467739 |
132 | macrophage activation (GO:0042116) | 2.72790787 |
133 | cytokine secretion (GO:0050663) | 2.72628464 |
134 | positive regulation of protein oligomerization (GO:0032461) | 2.71653161 |
135 | T-helper 1 type immune response (GO:0042088) | 2.68904637 |
136 | * positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67665984 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.96899262 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.92694233 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.70151201 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.74670251 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63057329 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57700914 |
7 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.37503171 |
8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.21668590 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.14247716 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.06339605 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05563897 |
12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.94036555 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.80382002 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79323243 |
15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.63308379 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57081975 |
17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.56016700 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54643129 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42541353 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.34619491 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22655659 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.19019575 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18021650 |
24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15943962 |
25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14898199 |
26 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05706886 |
27 | * MAF_26560356_Chip-Seq_TH1_Human | 1.98407882 |
28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91010919 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83868998 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 1.83531023 |
31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76079282 |
32 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75174416 |
33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73309559 |
34 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.68680264 |
35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66788683 |
36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66704705 |
37 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.65884085 |
38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65042434 |
39 | MYC_22102868_ChIP-Seq_BL_Human | 1.64311596 |
40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63594024 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.62396374 |
42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61318613 |
43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59127376 |
44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58715222 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54852888 |
46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52606227 |
47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52104964 |
48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52045615 |
49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.51829299 |
50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51508908 |
51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49852008 |
52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45403074 |
53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40323454 |
54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37431554 |
55 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36098100 |
56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35471511 |
57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34662573 |
58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31843900 |
59 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.31334823 |
60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31316925 |
61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30598722 |
62 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.30554493 |
63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29574496 |
64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29219800 |
65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28189814 |
66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27230338 |
67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25240251 |
68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24753593 |
69 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24416016 |
70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23858233 |
71 | MAF_26560356_Chip-Seq_TH2_Human | 1.21887128 |
72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21225446 |
73 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20829274 |
74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17405418 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15964490 |
76 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14416466 |
77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11488122 |
78 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09815485 |
79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09732611 |
80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09478135 |
81 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07439978 |
82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05903099 |
83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05476438 |
84 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04982371 |
85 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03221801 |
86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03050740 |
87 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.99530817 |
88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.99530817 |
89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.99530817 |
90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94622557 |
91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93818059 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93698376 |
93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92949358 |
94 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91586620 |
95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90515489 |
96 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88379586 |
97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85122751 |
98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84949896 |
99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84811703 |
100 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.83518821 |
101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82094306 |
102 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.81076871 |
103 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80943413 |
104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80413895 |
105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79469562 |
106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79306794 |
107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77591881 |
108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77467473 |
109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.77292659 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76155654 |
111 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75318396 |
112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75190404 |
113 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74857290 |
114 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.73418070 |
115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73179243 |
116 | P300_27268052_Chip-Seq_Bcells_Human | 0.71514480 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 4.19859864 |
2 | MP0003303_peritoneal_inflammation | 4.06361396 |
3 | MP0001835_abnormal_antigen_presentation | 3.81892831 |
4 | MP0009278_abnormal_bone_marrow | 3.63309775 |
5 | MP0009785_altered_susceptibility_to | 3.54268666 |
6 | * MP0002419_abnormal_innate_immunity | 3.22372255 |
7 | MP0002148_abnormal_hypersensitivity_rea | 3.04959792 |
8 | MP0000685_abnormal_immune_system | 2.97835738 |
9 | MP0005000_abnormal_immune_tolerance | 2.96177952 |
10 | MP0003724_increased_susceptibility_to | 2.86641675 |
11 | * MP0005025_abnormal_response_to | 2.85248216 |
12 | MP0006082_CNS_inflammation | 2.80880098 |
13 | MP0001790_abnormal_immune_system | 2.73011252 |
14 | MP0005387_immune_system_phenotype | 2.73011252 |
15 | MP0001800_abnormal_humoral_immune | 2.61383143 |
16 | * MP0002452_abnormal_antigen_presenting | 2.58050994 |
17 | MP0002405_respiratory_system_inflammati | 2.36926758 |
18 | MP0004510_myositis | 2.36595846 |
19 | * MP0002723_abnormal_immune_serum | 2.34576562 |
20 | MP0005058_abnormal_lysosome_morphology | 2.33947831 |
21 | * MP0001819_abnormal_immune_cell | 2.26003912 |
22 | * MP0002420_abnormal_adaptive_immunity | 2.25222334 |
23 | MP0005671_abnormal_response_to | 2.16142213 |
24 | MP0001853_heart_inflammation | 2.15683014 |
25 | MP0001545_abnormal_hematopoietic_system | 2.11221455 |
26 | MP0005397_hematopoietic_system_phenotyp | 2.11221455 |
27 | MP0005464_abnormal_platelet_physiology | 2.01774719 |
28 | MP0001533_abnormal_skeleton_physiology | 2.01424985 |
29 | * MP0001845_abnormal_inflammatory_respons | 1.87661646 |
30 | MP0000343_altered_response_to | 1.85877147 |
31 | MP0003075_altered_response_to | 1.84713897 |
32 | MP0005076_abnormal_cell_differentiation | 1.76611225 |
33 | MP0009764_decreased_sensitivity_to | 1.74536658 |
34 | MP0004947_skin_inflammation | 1.73831681 |
35 | MP0002138_abnormal_hepatobiliary_system | 1.72541764 |
36 | MP0010155_abnormal_intestine_physiology | 1.68104173 |
37 | * MP0000716_abnormal_immune_system | 1.67174225 |
38 | MP0002398_abnormal_bone_marrow | 1.65880190 |
39 | MP0003448_altered_tumor_morphology | 1.63287770 |
40 | MP0002006_tumorigenesis | 1.61130590 |
41 | MP0005451_abnormal_body_composition | 1.59081415 |
42 | MP0003172_abnormal_lysosome_physiology | 1.54489378 |
43 | MP0009333_abnormal_splenocyte_physiolog | 1.53138298 |
44 | MP0003191_abnormal_cellular_cholesterol | 1.52682287 |
45 | MP0000858_altered_metastatic_potential | 1.49947097 |
46 | MP0000689_abnormal_spleen_morphology | 1.49892164 |
47 | MP0003828_pulmonary_edema | 1.49043202 |
48 | MP0008469_abnormal_protein_level | 1.48192785 |
49 | MP0005167_abnormal_blood-brain_barrier | 1.46878096 |
50 | MP0003453_abnormal_keratinocyte_physiol | 1.43181386 |
51 | MP0002933_joint_inflammation | 1.39270869 |
52 | MP0005310_abnormal_salivary_gland | 1.36183997 |
53 | * MP0002429_abnormal_blood_cell | 1.35620322 |
54 | MP0002166_altered_tumor_susceptibility | 1.34665247 |
55 | MP0002722_abnormal_immune_system | 1.31720748 |
56 | MP0008057_abnormal_DNA_replication | 1.30257667 |
57 | MP0003300_gastrointestinal_ulcer | 1.28141807 |
58 | MP0005174_abnormal_tail_pigmentation | 1.26934765 |
59 | MP0001873_stomach_inflammation | 1.20482581 |
60 | MP0004381_abnormal_hair_follicle | 1.15444139 |
61 | MP0001851_eye_inflammation | 1.13716445 |
62 | MP0003183_abnormal_peptide_metabolism | 1.13588521 |
63 | MP0005166_decreased_susceptibility_to | 1.11922183 |
64 | MP0000465_gastrointestinal_hemorrhage | 1.11603452 |
65 | MP0002277_abnormal_respiratory_mucosa | 1.09229071 |
66 | MP0005390_skeleton_phenotype | 1.03623178 |
67 | MP0005164_abnormal_response_to | 1.01257604 |
68 | MP0002998_abnormal_bone_remodeling | 1.01147984 |
69 | MP0009840_abnormal_foam_cell | 0.99325454 |
70 | MP0003656_abnormal_erythrocyte_physiolo | 0.98127291 |
71 | MP0003566_abnormal_cell_adhesion | 0.97284822 |
72 | MP0008004_abnormal_stomach_pH | 0.94468655 |
73 | MP0004883_abnormal_blood_vessel | 0.91450542 |
74 | MP0003763_abnormal_thymus_physiology | 0.89837714 |
75 | MP0003806_abnormal_nucleotide_metabolis | 0.87641896 |
76 | MP0010352_gastrointestinal_tract_polyps | 0.87442527 |
77 | MP0000490_abnormal_crypts_of | 0.83520238 |
78 | MP0000371_diluted_coat_color | 0.83269598 |
79 | MP0005023_abnormal_wound_healing | 0.82861128 |
80 | MP0004808_abnormal_hematopoietic_stem | 0.80849899 |
81 | MP0000604_amyloidosis | 0.80279917 |
82 | MP0009763_increased_sensitivity_to | 0.79261679 |
83 | MP0002132_abnormal_respiratory_system | 0.76701983 |
84 | MP0002396_abnormal_hematopoietic_system | 0.76404640 |
85 | MP0003690_abnormal_glial_cell | 0.75438676 |
86 | MP0002254_reproductive_system_inflammat | 0.75335631 |
87 | MP0000249_abnormal_blood_vessel | 0.73826911 |
88 | MP0000015_abnormal_ear_pigmentation | 0.72016028 |
89 | MP0000703_abnormal_thymus_morphology | 0.70617045 |
90 | MP0003045_fibrosis | 0.69651936 |
91 | MP0009765_abnormal_xenobiotic_induced | 0.69514226 |
92 | MP0003866_abnormal_defecation | 0.67060584 |
93 | MP0005075_abnormal_melanosome_morpholog | 0.66552918 |
94 | MP0008260_abnormal_autophagy | 0.66461044 |
95 | MP0002019_abnormal_tumor_incidence | 0.65990082 |
96 | MP0001663_abnormal_digestive_system | 0.65339482 |
97 | MP0000569_abnormal_digit_pigmentation | 0.64959832 |
98 | MP0000920_abnormal_myelination | 0.64620614 |
99 | MP0001986_abnormal_taste_sensitivity | 0.64509208 |
100 | MP0003091_abnormal_cell_migration | 0.63809564 |
101 | MP0004782_abnormal_surfactant_physiolog | 0.63582920 |
102 | MP0008874_decreased_physiological_sensi | 0.62915308 |
103 | MP0010307_abnormal_tumor_latency | 0.62178138 |
104 | MP0002332_abnormal_exercise_endurance | 0.60915370 |
105 | MP0002009_preneoplasia | 0.59751533 |
106 | MP0001958_emphysema | 0.59711081 |
107 | MP0003279_aneurysm | 0.56856618 |
108 | MP0004130_abnormal_muscle_cell | 0.56352660 |
109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55573197 |
110 | MP0003638_abnormal_response/metabolism_ | 0.52938141 |
111 | MP0003795_abnormal_bone_structure | 0.51223679 |
112 | MP0000609_abnormal_liver_physiology | 0.51056762 |
113 | MP0000767_abnormal_smooth_muscle | 0.50498790 |
114 | MP0005319_abnormal_enzyme/_coenzyme | 0.50045770 |
115 | MP0003329_amyloid_beta_deposits | 0.49375631 |
116 | MP0002133_abnormal_respiratory_system | 0.47658840 |
117 | MP0009115_abnormal_fat_cell | 0.46949025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 8.31309080 |
2 | Eczematoid dermatitis (HP:0000976) | 7.82880686 |
3 | Recurrent bacterial skin infections (HP:0005406) | 7.43447759 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.36965584 |
5 | Mediastinal lymphadenopathy (HP:0100721) | 5.15173549 |
6 | Abnormality of macrophages (HP:0004311) | 5.10544899 |
7 | Obstructive lung disease (HP:0006536) | 4.91954268 |
8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.91954268 |
9 | Pustule (HP:0200039) | 4.75106009 |
10 | Gingivitis (HP:0000230) | 4.55299376 |
11 | Recurrent skin infections (HP:0001581) | 4.52615363 |
12 | Recurrent fungal infections (HP:0002841) | 4.48979226 |
13 | Myositis (HP:0100614) | 4.21808430 |
14 | Stomatitis (HP:0010280) | 4.11575993 |
15 | Systemic lupus erythematosus (HP:0002725) | 3.82358079 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.75628024 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 3.74933300 |
18 | Orchitis (HP:0100796) | 3.73968167 |
19 | Cellulitis (HP:0100658) | 3.58597593 |
20 | Urticaria (HP:0001025) | 3.54492304 |
21 | Increased IgM level (HP:0003496) | 3.52793018 |
22 | Vacuolated lymphocytes (HP:0001922) | 3.52170537 |
23 | Spontaneous hematomas (HP:0007420) | 3.47288929 |
24 | Dysostosis multiplex (HP:0000943) | 3.38085796 |
25 | Optic neuritis (HP:0100653) | 3.35752456 |
26 | Retrobulbar optic neuritis (HP:0100654) | 3.35752456 |
27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26719751 |
28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26719751 |
29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26719751 |
30 | Meningitis (HP:0001287) | 3.24358081 |
31 | Vasculitis (HP:0002633) | 3.05690258 |
32 | T lymphocytopenia (HP:0005403) | 3.00953714 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00532446 |
34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00532446 |
35 | Chest pain (HP:0100749) | 2.99682870 |
36 | Interstitial pulmonary disease (HP:0006530) | 2.93221355 |
37 | Amyloidosis (HP:0011034) | 2.90543936 |
38 | Recurrent viral infections (HP:0004429) | 2.90383549 |
39 | Periodontitis (HP:0000704) | 2.90375660 |
40 | Episodic fever (HP:0001954) | 2.88784692 |
41 | Increased cerebral lipofuscin (HP:0011813) | 2.84575389 |
42 | Mucopolysacchariduria (HP:0008155) | 2.80941242 |
43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.80941242 |
44 | Colitis (HP:0002583) | 2.79963942 |
45 | Inflammation of the large intestine (HP:0002037) | 2.70400276 |
46 | Hematochezia (HP:0002573) | 2.64976734 |
47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64140691 |
48 | IgM deficiency (HP:0002850) | 2.62435213 |
49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57595754 |
50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57595754 |
51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57595754 |
52 | Gastrointestinal inflammation (HP:0004386) | 2.55885929 |
53 | Recurrent lower respiratory tract infections (HP:0002783) | 2.55244123 |
54 | Hypochromic microcytic anemia (HP:0004840) | 2.54784384 |
55 | Myocardial infarction (HP:0001658) | 2.54646069 |
56 | Cheilitis (HP:0100825) | 2.53218124 |
57 | Recurrent pneumonia (HP:0006532) | 2.51124456 |
58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49747975 |
59 | Panhypogammaglobulinemia (HP:0003139) | 2.48873758 |
60 | Purpura (HP:0000979) | 2.39920563 |
61 | Granulocytopenia (HP:0001913) | 2.39699303 |
62 | Gangrene (HP:0100758) | 2.38046280 |
63 | Keratoconjunctivitis sicca (HP:0001097) | 2.36916578 |
64 | Glomerulonephritis (HP:0000099) | 2.35268260 |
65 | Increased serum ferritin (HP:0003281) | 2.34199999 |
66 | Hemoptysis (HP:0002105) | 2.32784329 |
67 | Leukocytosis (HP:0001974) | 2.31269035 |
68 | Gingival bleeding (HP:0000225) | 2.30436037 |
69 | Abnormality of the pleura (HP:0002103) | 2.27490626 |
70 | Osteomyelitis (HP:0002754) | 2.25862235 |
71 | Pulmonary infiltrates (HP:0002113) | 2.20188681 |
72 | Nephritis (HP:0000123) | 2.16108671 |
73 | Abnormality of the nasal mucosa (HP:0000433) | 2.15683705 |
74 | Hypergammaglobulinemia (HP:0010702) | 2.15661214 |
75 | Hypochromic anemia (HP:0001931) | 2.14353181 |
76 | Keratoconjunctivitis (HP:0001096) | 2.13560746 |
77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11804726 |
78 | Arterial thrombosis (HP:0004420) | 2.11696266 |
79 | Disinhibition (HP:0000734) | 2.11319960 |
80 | Sepsis (HP:0100806) | 2.10691053 |
81 | Polycythemia (HP:0001901) | 2.10452974 |
82 | Agammaglobulinemia (HP:0004432) | 2.10312923 |
83 | Skin ulcer (HP:0200042) | 2.09794929 |
84 | Abnormality of iron homeostasis (HP:0011031) | 2.09079830 |
85 | Glomerulopathy (HP:0100820) | 2.08983300 |
86 | Abnormality of T cell physiology (HP:0011840) | 2.08491747 |
87 | Vertigo (HP:0002321) | 2.08287919 |
88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08106578 |
89 | Epistaxis (HP:0000421) | 2.07124182 |
90 | Premature loss of primary teeth (HP:0006323) | 2.05839000 |
91 | Anorexia (HP:0002039) | 2.05827389 |
92 | Prostate neoplasm (HP:0100787) | 2.05692978 |
93 | Abnormality of the peritoneum (HP:0002585) | 2.05185619 |
94 | Eosinophilia (HP:0001880) | 2.04887976 |
95 | Hepatosplenomegaly (HP:0001433) | 2.03029861 |
96 | Abnormality of the endocardium (HP:0004306) | 2.02272838 |
97 | Albinism (HP:0001022) | 2.01327244 |
98 | Axonal loss (HP:0003447) | 2.00980453 |
99 | Gastrointestinal stroma tumor (HP:0100723) | 2.00519784 |
100 | Spondylolisthesis (HP:0003302) | 2.00518782 |
101 | Polyneuropathy (HP:0001271) | 1.99985205 |
102 | Abnormal platelet volume (HP:0011876) | 1.99481673 |
103 | Gastrointestinal infarctions (HP:0005244) | 1.99098411 |
104 | Abnormality of T cells (HP:0002843) | 1.95847282 |
105 | Prolonged bleeding time (HP:0003010) | 1.93827549 |
106 | Pulmonary embolism (HP:0002204) | 1.93827363 |
107 | Encephalitis (HP:0002383) | 1.92947873 |
108 | Keratitis (HP:0000491) | 1.92664077 |
109 | Joint hemorrhage (HP:0005261) | 1.92615801 |
110 | Slow saccadic eye movements (HP:0000514) | 1.91862107 |
111 | Chronic otitis media (HP:0000389) | 1.91669019 |
112 | Microcytic anemia (HP:0001935) | 1.91419868 |
113 | Abnormality of T cell number (HP:0011839) | 1.91012527 |
114 | Acne (HP:0001061) | 1.90456136 |
115 | Petechiae (HP:0000967) | 1.90022835 |
116 | Amaurosis fugax (HP:0100576) | 1.89332803 |
117 | IgA deficiency (HP:0002720) | 1.88794149 |
118 | Loss of speech (HP:0002371) | 1.85764333 |
119 | Nasal polyposis (HP:0100582) | 1.84100628 |
120 | Peritonitis (HP:0002586) | 1.82328943 |
121 | Increased IgE level (HP:0003212) | 1.81815466 |
122 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81055971 |
123 | Lower limb hyperreflexia (HP:0002395) | 1.79763210 |
124 | Basal ganglia calcification (HP:0002135) | 1.79052191 |
125 | Abnormality of complement system (HP:0005339) | 1.77599036 |
126 | Thick nail (HP:0001805) | 1.75549396 |
127 | Restrictive lung disease (HP:0002091) | 1.74092428 |
128 | Agnosia (HP:0010524) | 1.72975556 |
129 | Recurrent sinusitis (HP:0011108) | 1.72485912 |
130 | Lymphopenia (HP:0001888) | 1.70323457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 4.46797649 |
2 | MAP4K1 | 3.93696386 |
3 | RIPK4 | 3.84011606 |
4 | IRAK4 | 3.62346062 |
5 | MAP3K14 | 2.85770319 |
6 | * CSK | 2.62924740 |
7 | PRPF4B | 2.60144381 |
8 | TYK2 | 2.46988458 |
9 | MATK | 2.38132287 |
10 | ERN1 | 2.28547338 |
11 | TBK1 | 2.26561524 |
12 | STK10 | 2.15524316 |
13 | IRAK3 | 2.08829867 |
14 | MAP3K11 | 2.00777267 |
15 | EPHB1 | 1.96120089 |
16 | TAOK1 | 1.79116716 |
17 | MAP3K6 | 1.74551089 |
18 | CLK1 | 1.70681842 |
19 | TRPM7 | 1.68846388 |
20 | IKBKB | 1.67529003 |
21 | TXK | 1.62281614 |
22 | BTK | 1.61901240 |
23 | ZAP70 | 1.56878141 |
24 | HCK | 1.54970167 |
25 | ICK | 1.54323485 |
26 | BMX | 1.50714562 |
27 | PIM1 | 1.47591603 |
28 | PIM2 | 1.40688556 |
29 | JAK3 | 1.37157193 |
30 | FES | 1.35622119 |
31 | IKBKE | 1.35360188 |
32 | SIK3 | 1.32571943 |
33 | MAPK15 | 1.32472489 |
34 | LYN | 1.31867173 |
35 | CSF1R | 1.30597116 |
36 | GRK6 | 1.30328874 |
37 | YES1 | 1.29540828 |
38 | JAK1 | 1.27979857 |
39 | TEC | 1.27448931 |
40 | KIT | 1.26658242 |
41 | MAP3K1 | 1.21454066 |
42 | SYK | 1.17451968 |
43 | TGFBR2 | 1.16043747 |
44 | KSR2 | 1.15894901 |
45 | DDR2 | 1.11598435 |
46 | * FGR | 1.10463484 |
47 | LRRK2 | 1.05046355 |
48 | LCK | 1.02885071 |
49 | MAP2K3 | 1.02269846 |
50 | MAP3K13 | 1.00830451 |
51 | CHUK | 0.98641068 |
52 | JAK2 | 0.98048360 |
53 | IRAK2 | 0.96276204 |
54 | MARK2 | 0.94824404 |
55 | TRIB3 | 0.93855447 |
56 | IRAK1 | 0.93166624 |
57 | DAPK1 | 0.92918763 |
58 | RPS6KA6 | 0.91552672 |
59 | RPS6KL1 | 0.90218168 |
60 | RPS6KC1 | 0.90218168 |
61 | PDPK1 | 0.85539579 |
62 | MARK3 | 0.84551045 |
63 | RIPK1 | 0.84097142 |
64 | ITK | 0.82201574 |
65 | ERBB3 | 0.79476019 |
66 | CDC42BPA | 0.78884542 |
67 | MAPK12 | 0.76422651 |
68 | TESK2 | 0.73896201 |
69 | RPS6KA4 | 0.73330157 |
70 | CDK6 | 0.73120452 |
71 | SIK2 | 0.71722922 |
72 | EGFR | 0.71094004 |
73 | MAPK7 | 0.70882418 |
74 | PRKCD | 0.70780197 |
75 | MAPKAPK2 | 0.68295192 |
76 | CDK19 | 0.68106329 |
77 | DYRK1B | 0.65140214 |
78 | MAP3K7 | 0.62202276 |
79 | ABL1 | 0.61220585 |
80 | * FYN | 0.61109551 |
81 | MAPK11 | 0.59688428 |
82 | MAPK4 | 0.59494054 |
83 | KDR | 0.57064205 |
84 | MAP3K12 | 0.54778732 |
85 | TAOK3 | 0.54702166 |
86 | PRKD2 | 0.54641603 |
87 | FGFR4 | 0.54601876 |
88 | SGK3 | 0.54096386 |
89 | PIK3CG | 0.53598511 |
90 | FGFR3 | 0.52856664 |
91 | GRK7 | 0.52820136 |
92 | MAP3K2 | 0.52040115 |
93 | RPS6KA1 | 0.51833494 |
94 | MAP2K4 | 0.50667656 |
95 | GSK3A | 0.50448865 |
96 | CAMKK1 | 0.49752570 |
97 | MST4 | 0.48658102 |
98 | PTK6 | 0.48591886 |
99 | TTN | 0.48195584 |
100 | MOS | 0.48082533 |
101 | STK11 | 0.47325842 |
102 | TAOK2 | 0.47284086 |
103 | SMG1 | 0.47050653 |
104 | ALK | 0.45853774 |
105 | TYRO3 | 0.45768584 |
106 | CDK7 | 0.45695186 |
107 | STK4 | 0.44724497 |
108 | SIK1 | 0.44173351 |
109 | PTK2B | 0.43823756 |
110 | MAP3K10 | 0.43591419 |
111 | HIPK2 | 0.43452076 |
112 | PAK4 | 0.41949361 |
113 | BMPR2 | 0.41443310 |
114 | PTK2 | 0.40013827 |
115 | CDK12 | 0.39797387 |
116 | CAMKK2 | 0.39534298 |
117 | MAP3K5 | 0.39146878 |
118 | DAPK2 | 0.39089294 |
119 | MAP3K3 | 0.38815122 |
120 | ABL2 | 0.37480183 |
121 | RET | 0.37148384 |
122 | TNK2 | 0.37053530 |
123 | MAP2K6 | 0.35415145 |
124 | MAP3K8 | 0.35406068 |
125 | EPHA3 | 0.34997593 |
126 | RAF1 | 0.34779927 |
127 | KSR1 | 0.34518231 |
128 | PRKG2 | 0.33921023 |
129 | SGK2 | 0.31809924 |
130 | CAMK1D | 0.30457830 |
131 | PRKCQ | 0.30444816 |
132 | DMPK | 0.29947570 |
133 | PDK1 | 0.28069206 |
134 | PRKCH | 0.27791589 |
135 | NEK9 | 0.27549393 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.96502564 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.81586113 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.63357181 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57761343 |
5 | Legionellosis_Homo sapiens_hsa05134 | 2.54118003 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43718644 |
7 | Tuberculosis_Homo sapiens_hsa05152 | 2.36868899 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.33310476 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.24695832 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08880191 |
11 | Shigellosis_Homo sapiens_hsa05131 | 2.01817546 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99602548 |
13 | Salmonella infection_Homo sapiens_hsa05132 | 1.93045931 |
14 | Malaria_Homo sapiens_hsa05144 | 1.92833295 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88754872 |
16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88320338 |
17 | Measles_Homo sapiens_hsa05162 | 1.86199922 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84844443 |
19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78582854 |
20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77985823 |
21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76521021 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.72122062 |
23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69759920 |
24 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63345424 |
25 | Asthma_Homo sapiens_hsa05310 | 1.61148781 |
26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60422240 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.57814106 |
28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.54910573 |
29 | Allograft rejection_Homo sapiens_hsa05330 | 1.54820247 |
30 | Phagosome_Homo sapiens_hsa04145 | 1.52311283 |
31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45699575 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44387495 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42542861 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.39754251 |
35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39699334 |
36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36965205 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34676360 |
38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33692600 |
39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29337993 |
40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28364462 |
41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28059703 |
42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27864400 |
43 | Apoptosis_Homo sapiens_hsa04210 | 1.23227078 |
44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21146406 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.18434818 |
46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05108072 |
47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04250793 |
48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04249106 |
49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04107742 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01484635 |
51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98302681 |
52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88968015 |
53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88901524 |
54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85396432 |
55 | Amoebiasis_Homo sapiens_hsa05146 | 0.82735889 |
56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82623434 |
57 | Hepatitis C_Homo sapiens_hsa05160 | 0.81631365 |
58 | Platelet activation_Homo sapiens_hsa04611 | 0.81539639 |
59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80862855 |
60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77318144 |
61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76869196 |
62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76110183 |
63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76088779 |
64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75266312 |
65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74670131 |
66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74057963 |
67 | Base excision repair_Homo sapiens_hsa03410 | 0.72737180 |
68 | Adherens junction_Homo sapiens_hsa04520 | 0.71293014 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69802307 |
70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69338558 |
71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68821163 |
72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66435976 |
73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63415593 |
74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62233881 |
75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62006036 |
76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60692422 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60535248 |
78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56424625 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55542248 |
80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55515008 |
81 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53277594 |
82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51473912 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50684834 |
84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50523401 |
85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49024283 |
86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49000172 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.48028138 |
88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47578228 |
89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47319947 |
90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45623650 |
91 | Bladder cancer_Homo sapiens_hsa05219 | 0.44466762 |
92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44403149 |
93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40850107 |
94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39603523 |
95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38242441 |
96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38048294 |
97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37558657 |
98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37445997 |
99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36607815 |
100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36320864 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.35506278 |
102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34510872 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.33788944 |
104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32547172 |
105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32405735 |
106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31442737 |
107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31313317 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29735907 |
109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29550499 |
110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28534754 |
111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27490000 |
112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26890087 |
113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26755640 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25581288 |
115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20888944 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.18369082 |
117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17586425 |
118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17002993 |
119 | Mismatch repair_Homo sapiens_hsa03430 | 0.15837441 |